NCT05089357View on ClinicalTrials.gov

Non-interventional Study, Long Term Treatment on Glabellar Lines With Dysport® in Subjects of Chinese Origin

CompletedOBSERVATIONAL

Enrollment

250

Participants

Timeline

Start Date

November 11, 2021

Primary Completion Date

September 12, 2023

Study Completion Date

December 24, 2023

Conditions

Glabellar Lines

Interventions

BIOLOGICAL

AbobotulinumtoxinA

Participants received a total dose of AbobotulinumtoxinA (Dysport®), 50 U (0.25 mL total; 10 U \[0.05 mL per injection site\] of study drug into 5 injection sites intramuscularly.

Trial Locations (1)

Unknown

Hangzhou Yanshuyuerong medical cosmetology clinic, Hangzhou